Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, Kaposi sarcoma
Results 1-11 of 11 for your search:
Start Over
Pomalidomide in Treating Patients with Kaposi Sarcoma with or without HIV
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0047, NCI-2013-01525, 120047, P11847, PO-KS-NCI-0050, NCT01495598
Pegylated Liposomal Doxorubicin Hydrochloride and Bevacizumab in Treating Patients with Advanced Kaposi Sarcoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09-C-0130, NCI-2013-01450, 090130, NCT00902239, P09493, NCT00923936
Gamma Secretase Inhibitor PF-03084014 in Treating Patients with AIDS-Associated Kaposi Sarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AMC-089, NCI-2014-00638, NCT02137564
Nivolumab and Ipilimumab in Treating Patients with Advanced HIV Associated Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: AMC-095, NCI-2015-00461, NCT02408861
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 18 and over
Trial IDs: AMC-058, NCI-2009-00393, CDR0000590397, NCT00695422
Iodine I 124-FIAU Positron Emission Tomography And Computed Tomography in Assessing Viral Expression in Patients with Epstein-Barr Virus and Kaposi Sarcoma Herpes Virus-Associated Cancer
Phase: No phase specified
Type: Diagnostic
Age: 18 to 75
Trial IDs: J09111, NCI-2009-01398, NA_00032681 / CIR00009387, NCT00982449
Natural History of Zidovudine and Valganciclovir or Rituximab and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients with Kaposi Sarcoma-Associated Herpes Virus
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Age: 18 and over
Trial IDs: 11-C-0220, NCI-2013-01499, 110220, P10760, NCT01419561
Nelfinavir Mesylate in Treating Patients with Epstein-Barr Virus or Kaposi Sarcoma-Associated Herpesvirus Positive Malignancies
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J13174, NCI-2014-01534, NA_00092477, NA _00092477 / CIR00004163, NCT02080416
Natural History Studies in Samples From Patients With Rare Skin Diseases or Diseases With Skin Involvement
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Any age
Trial IDs: 96-C-0102, NCI-2013-02070, 960102, NCT00019149, NCT00001506
Laser Doppler Imaging, Multi-Spectral Imaging, Infrared Thermal Imaging, and Optical Coherence Tomography in Assessing Tumor Vascularity in Patients with Kaposi Sarcoma
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 01-C-0158, NCI-2013-02024, 010158, NIH-2514-1 (07-09), P.A.: 09-25-0099, NCT00026793
Start Over